Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Jaslok Hospital & Research Centre

Verified

Basic Information

Site Overview

Source: Human-provided.

Jaslok Hospital & Research Centre in Mumbai, India is a leading tertiary care and cancer treatment centre with a long legacy in oncology. Its Department of Medical Oncology was established over 35 years ago by Dr. Suresh H. Advani, a pioneer in the field in India, and remains one of the country’s most respected oncology units. The department provides comprehensive cancer diagnosis and treatment, including chemotherapy, immunotherapy, targeted therapies, biological treatments, hormone therapies, and clinical/experimental therapies, for cancers such as leukaemia, lymphoma, breast, colon, prostate, lung, and neuroendocrine tumours. It sees hundreds of outpatients and inpatients weekly, with specialised nursing staff and support services that include patient education, counselling, and multidisciplinary care. The unit also engages in ongoing clinical research and trials, offering advanced treatment options under expert oncologists using state-of-the-art technology.

Source: Trial-derived.
22Total Trials
Source: Trial-derived.
2Recruiting Trials
Source: Trial-derived.
2Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
27Unique Conditions
Source: Trial-derived.
22Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Focal Epilepsy (2)Source: Trial-derived. Genetic Syndrome (2)Source: Trial-derived. Antiplatelet Drugs (1)Source: Trial-derived. Ataxia Telangiectasia (1)Source: Trial-derived. Breast Cancer (1)Source: Trial-derived. COVID-19 (1)Source: Trial-derived. Critical Illness (1)Source: Trial-derived. Diffuse Large B-cell Lymphoma (1)

Sponsors

Source: Trial-derived. Bayer (2)Source: Trial-derived. Biohaven Therapeutics Ltd. (2)Source: Trial-derived. Karyopharm Therapeutics Inc (2)Source: Trial-derived. Quince Therapeutics S.p.A. (2)Source: Trial-derived. Boston Scientific Corporation (1)Source: Trial-derived. CardioVascular Research Foundation, Korea (1)Source: Trial-derived. Eisai Inc. (1)Source: Trial-derived. Epygenix (1)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Bone marrow biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Serum and urine protein electrophoresis / immunofixation